Listed

Longevity Health Holdings, Inc.

XAGEOTCCIK 1842939Consumer staplesFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$396.0k, Q2 FY2026
Operating income−$724.1k, Q2 FY2026
Net income−$1.9m, Q2 FY2026
Longevity Health Holdings, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$12.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$20.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$17.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.5Revenue, Q1 FY2025, three months to 2025-03-31$510.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.5Revenue, Q2 FY2025, three months to 2025-06-30$503.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure0.4Revenue, Q3 FY2025, three months to 2025-09-30$425.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.5Revenue, Q4 FY2025, three months to 2025-12-31$473.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.4Revenue, Q1 FY2026, three months to 2026-03-31$391.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.4Revenue, Q2 FY2026, three months to 2026-06-30$396.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Cost of revenue$m0.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$292. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.8k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.2k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.2Cost of revenue, Q1 FY2025, three months to 2025-03-31$240.5k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.2Cost of revenue, Q2 FY2025, three months to 2025-06-30$201.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure0.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$171.4k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$205.2k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$154.7k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$160.5k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Gross profit$m0.0Gross profit, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.0Gross profit, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure0.0Gross profit, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.0Gross profit, Q2 FY2024, three months to 2024-06-30$12.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.0Gross profit, Q3 FY2024, three months to 2024-09-30$15.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.0Gross profit, Q4 FY2024, three months to 2024-12-31$16.3k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.3Gross profit, Q1 FY2025, three months to 2025-03-31$269.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.3Gross profit, Q2 FY2025, three months to 2025-06-30$302.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure0.3Gross profit, Q3 FY2025, three months to 2025-09-30$254.5k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.3Gross profit, Q4 FY2025, three months to 2025-12-31$267.8k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.2Gross profit, Q1 FY2026, three months to 2026-03-31$237.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.2Gross profit, Q2 FY2026, three months to 2026-06-30$235.5k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Research and development$m1.6Research and development, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure(0.7)Research and development, Q4 FY2023, three months to 2023-12-31−$657.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure0.4Research and development, Q1 FY2024, three months to 2024-03-31$429.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.1Research and development, Q2 FY2024, three months to 2024-06-30$104.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.3Research and development, Q3 FY2024, three months to 2024-09-30$331.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.2Research and development, Q4 FY2024, three months to 2024-12-31$189.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.2Research and development, Q1 FY2025, three months to 2025-03-31$196.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.2Research and development, Q2 FY2025, three months to 2025-06-30$228.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure0.2Research and development, Q3 FY2025, three months to 2025-09-30$228.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.1Research and development, Q4 FY2025, three months to 2025-12-31$104.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.1Research and development, Q1 FY2026, three months to 2026-03-31$55.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.1Research and development, Q2 FY2026, three months to 2026-06-30$73.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Operating income$m(2.8)Operating income, Q3 FY2023, three months to 2023-09-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure(0.3)Operating income, Q4 FY2023, three months to 2023-12-31−$333.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Operating income, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure(1.2)Operating income, Q2 FY2024, three months to 2024-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure(1.4)Operating income, Q3 FY2024, three months to 2024-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(1.0)Operating income, Q4 FY2024, three months to 2024-12-31−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Operating income, Q1 FY2025, three months to 2025-03-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(1.9)Operating income, Q2 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(1.5)Operating income, Q3 FY2025, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(2.3)Operating income, Q4 FY2025, three months to 2025-12-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating income, Q1 FY2026, three months to 2026-03-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(0.7)Operating income, Q2 FY2026, three months to 2026-06-30−$724.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$18.2k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$15.4k. XBRL concept us-gaap:InterestExpense. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$11.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$3.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$7.1k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$7.5k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$5.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$2.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$5.1k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$5.6k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$3.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figurenot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-12-31−$97.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$36.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Net income$m(11.5)Net income, Q3 FY2023, three months to 2023-09-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure3.2Net income, Q4 FY2023, three months to 2023-12-31$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Net income, Q1 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure(3.3)Net income, Q2 FY2024, three months to 2024-06-30−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure(2.9)Net income, Q3 FY2024, three months to 2024-09-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(0.9)Net income, Q4 FY2024, three months to 2024-12-31−$914.3k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Net income, Q1 FY2025, three months to 2025-03-31−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(1.9)Net income, Q2 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(1.4)Net income, Q3 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(2.1)Net income, Q4 FY2025, three months to 2025-12-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Net income, Q1 FY2026, three months to 2026-03-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(1.9)Net income, Q2 FY2026, three months to 2026-06-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Diluted EPS$ per share(0.62)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figurenot reported(4.28)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$4.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure(4.78)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$4.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure(4.13)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$4.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figurenot reported(1.52)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(1.56)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure(0.83)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figurenot reported(0.75)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figurenot reported
Basic EPS$ per share(0.62)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figurenot reported(4.28)Basic EPS, Q1 FY2024, three months to 2024-03-31−$4.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure(4.78)Basic EPS, Q2 FY2024, three months to 2024-06-30−$4.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure(4.13)Basic EPS, Q3 FY2024, three months to 2024-09-30−$4.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figurenot reported(1.52)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(1.56)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(0.83)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figurenot reported(0.75)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(0.76)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure

Balance sheet

Cash and equivalents$35.5k, Q2 FY2026
Long-term debt$9.4m, Q3 FY2023
Shareholders' equity−$8.7m, Q2 FY2026
Longevity Health Holdings, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m8.0Cash and equivalents, Q3 FY2023, at 2023-09-30$8.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figure2.9Cash and equivalents, FY2023, at 2023-12-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-04-01, accession 0000950170-24-038992.Report this figure0.9Cash and equivalents, Q1 FY2024, at 2024-03-31$892.2k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0000950170-24-060506.Report this figure2.2Cash and equivalents, Q2 FY2024, at 2024-06-30$2.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0000950170-24-097039.Report this figure1.1Cash and equivalents, Q3 FY2024, at 2024-09-30$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.2Cash and equivalents, FY2024, at 2024-12-31$157.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134698.Report this figure0.8Cash and equivalents, Q1 FY2025, at 2025-03-31$770.0k. XBRL concept us-gaap:Cash. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure1.6Cash and equivalents, Q2 FY2025, at 2025-06-30$1.6m. XBRL concept us-gaap:Cash. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure1.1Cash and equivalents, Q3 FY2025, at 2025-09-30$1.1m. XBRL concept us-gaap:Cash. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure0.7Cash and equivalents, FY2025, at 2025-12-31$706.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure0.3Cash and equivalents, Q1 FY2026, at 2026-03-31$313.4k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.0Cash and equivalents, Q2 FY2026, at 2026-06-30$35.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Current assets$m38.9Current assets, Q3 FY2023, at 2023-09-30$38.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figure62.9Current assets, FY2023, at 2023-12-31$62.9m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2025-06-17, accession 0000950170-25-087485.Report this figure5.2Current assets, Q1 FY2024, at 2024-03-31$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060506.Report this figure4.1Current assets, Q2 FY2024, at 2024-06-30$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097039.Report this figure1.9Current assets, Q3 FY2024, at 2024-09-30$1.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure1.0Current assets, FY2024, at 2024-12-31$955.6k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134698.Report this figure2.8Current assets, Q1 FY2025, at 2025-03-31$2.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure3.2Current assets, Q2 FY2025, at 2025-06-30$3.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure2.8Current assets, Q3 FY2025, at 2025-09-30$2.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure2.0Current assets, FY2025, at 2025-12-31$2.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure1.3Current assets, Q1 FY2026, at 2026-03-31$1.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure0.7Current assets, Q2 FY2026, at 2026-06-30$711.7k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Total assets$m82.2Total assets, Q3 FY2023, at 2023-09-30$82.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figure63.9Total assets, FY2023, at 2023-12-31$63.9m. XBRL concept us-gaap:Assets. 10-K/A filed 2025-06-17, accession 0000950170-25-087485.Report this figure6.2Total assets, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060506.Report this figure5.0Total assets, Q2 FY2024, at 2024-06-30$5.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-097039.Report this figure2.4Total assets, Q3 FY2024, at 2024-09-30$2.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure1.5Total assets, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-134698.Report this figure3.3Total assets, Q1 FY2025, at 2025-03-31$3.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure3.7Total assets, Q2 FY2025, at 2025-06-30$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure3.3Total assets, Q3 FY2025, at 2025-09-30$3.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure2.4Total assets, FY2025, at 2025-12-31$2.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure1.6Total assets, Q1 FY2026, at 2026-03-31$1.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure1.1Total assets, Q2 FY2026, at 2026-06-30$1.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Current liabilities$m37.7Current liabilities, Q3 FY2023, at 2023-09-30$37.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figure38.5Current liabilities, FY2023, at 2023-12-31$38.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2025-06-17, accession 0000950170-25-087485.Report this figure6.9Current liabilities, Q1 FY2024, at 2024-03-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060506.Report this figure5.8Current liabilities, Q2 FY2024, at 2024-06-30$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097039.Report this figure6.2Current liabilities, Q3 FY2024, at 2024-09-30$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure5.9Current liabilities, FY2024, at 2024-12-31$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134698.Report this figure6.6Current liabilities, Q1 FY2025, at 2025-03-31$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure6.9Current liabilities, Q2 FY2025, at 2025-06-30$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure6.8Current liabilities, Q3 FY2025, at 2025-09-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure7.9Current liabilities, FY2025, at 2025-12-31$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure8.3Current liabilities, Q1 FY2026, at 2026-03-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure9.6Current liabilities, Q2 FY2026, at 2026-06-30$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Total liabilities$m61.3Total liabilities, Q3 FY2023, at 2023-09-30$61.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figure39.2Total liabilities, FY2023, at 2023-12-31$39.2m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2025-06-17, accession 0000950170-25-087485.Report this figure7.6Total liabilities, Q1 FY2024, at 2024-03-31$7.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060506.Report this figure6.4Total liabilities, Q2 FY2024, at 2024-06-30$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-097039.Report this figure6.5Total liabilities, Q3 FY2024, at 2024-09-30$6.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure6.2Total liabilities, FY2024, at 2024-12-31$6.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001193125-26-134698.Report this figure7.1Total liabilities, Q1 FY2025, at 2025-03-31$7.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure7.5Total liabilities, Q2 FY2025, at 2025-06-30$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure7.3Total liabilities, Q3 FY2025, at 2025-09-30$7.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure8.2Total liabilities, FY2025, at 2025-12-31$8.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure8.5Total liabilities, Q1 FY2026, at 2026-03-31$8.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure9.8Total liabilities, Q2 FY2026, at 2026-06-30$9.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure
Long-term debt$m9.4Long-term debt, Q3 FY2023, at 2023-09-30$9.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m20.9Shareholders' equity, Q3 FY2023, at 2023-09-30$20.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure24.7Shareholders' equity, FY2023, at 2023-12-31$24.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-134698.Report this figure(1.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$1.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure(1.4)Shareholders' equity, Q2 FY2024, at 2024-06-30−$1.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(4.1)Shareholders' equity, Q3 FY2024, at 2024-09-30−$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(4.7)Shareholders' equity, FY2024, at 2024-12-31−$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(3.8)Shareholders' equity, Q1 FY2025, at 2025-03-31−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(3.7)Shareholders' equity, Q2 FY2025, at 2025-06-30−$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(4.0)Shareholders' equity, Q3 FY2025, at 2025-09-30−$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure(5.9)Shareholders' equity, FY2025, at 2025-12-31−$5.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(6.9)Shareholders' equity, Q1 FY2026, at 2026-03-31−$6.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure(8.7)Shareholders' equity, Q2 FY2026, at 2026-06-30−$8.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure

Cash flow

Operating cash flow−$223.9k, Q2 FY2026
Capital expenditure$1, Q4 FY2025
Share repurchases$0, Q4 FY2023
Longevity Health Holdings, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(3,981)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-126725. Derived: 9-month figure less the 6-month figure.Report this figure(3,411)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figure(1,076)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure(1,138)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108973. Derived: 6-month figure less the 3-month figure.Report this figure(907)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$906.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-283127. Derived: 9-month figure less the 6-month figure.Report this figure(772)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$772.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure(753)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$753.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(836)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$836.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001437749-26-028043. Derived: 6-month figure less the 3-month figure.Report this figure(1,434)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-283127. Derived: 9-month figure less the 6-month figure.Report this figure(306)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$306.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figure(485)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$485.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure(224)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$223.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001437749-26-028043. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-126725. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2025-06-17, accession 0000950170-25-087485. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$1. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001193125-26-134698. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Share repurchases$knot reported0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2024-04-01, accession 0000950170-24-038992. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)1.90m, Q1 FY2026
Longevity Health Holdings, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31
Diluted shares (weighted)m shares0.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30913,655 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-15, accession 0000950170-23-063884.Report this figure1.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,122,529 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-060506.Report this figure1.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,124,601 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-097039.Report this figure18.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3018,629,730 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-126725.Report this figure0.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31763,839 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-072858.Report this figure0.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30691,167 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure0.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30696,847 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure1.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31991,210 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure1.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,209,809 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108973.Report this figure1.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,723,434 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-283127.Report this figure1.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,899,910 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-224428.Report this figure

Shares outstanding: 2.48mShares outstanding, period not labelled, at 2026-08-132,475,321 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001437749-26-028043.Report this figure at Aug 13, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.